Visium Asset Management’s Gilead Sciences GILD Stock Holding History

Visium Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-752,693	Closed	-$69.1M	–	402
2016 Q1	$69.1M	Buy	752,693 +749,179	+21,320%	+$67.6M	1.18%	11
2015 Q4	$356K	Buy	3,514 +714	+26%	+$74.3K	0.01%	517
2015 Q3	$275K	Buy	+2,800	New	+$311K	﹤0.01%	711
2015 Q2	–	Sell	-9,050	Closed	-$888K	–	1195
2015 Q1	$888K	Buy	9,050 +2,800	+45%	+$284K	0.01%	544
2014 Q4	$590K	Sell	6,250 -4,116	-40%	-$426K	0.01%	662
2014 Q3	$1.1M	Sell	10,366 -1,700	-14%	-$166K	0.02%	566
2014 Q2	$1M	Sell	12,066 -50	-0.4%	-$3.89K	0.02%	532
2014 Q1	$859K	Sell	12,116 -1,097,797	-99%	-$86.1M	0.01%	504
2013 Q4	$83.4M	Sell	1,109,913 -304,196	-22%	-$21.2M	1.64%	8
2013 Q3	$88.9M	Sell	1,414,109 -857,932	-38%	-$51.3M	2.02%	8
2013 Q2	$116M	Buy	+2,272,041	New	+$118M	2.72%	8

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Visium Asset Management's GILD Position: Q2 2016 in Review

Visium Asset Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 752,693 shares — an estimated $69.1M sold.

Visium Asset Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $116M in Q2 2013. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Visium Asset Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 752,693 Gilead Sciences shares in Q2 2016, an estimated $69.1M.
Visium Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Visium Asset Management's Gilead Sciences position peaked at $116M in Q2 2013.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.